Mycophenolate mofetil Good Manufacturer supply High Quality 128794-94-5
- Molecular Formula:C23H31NO7
- Molecular Weight:433.502
- Appearance/Colour:White powder
- Vapor Pressure:7.51E-17mmHg at 25°C
- Melting Point:95-96 °C
- Refractive Index:1.557
- Boiling Point:637.6 °C at 760 mmHg
- PKA:5.6(at 25℃)
- Flash Point:339.4 °C
- PSA：94.53000
- Density:1.222 g/cm3
- LogP:2.46190
Mycophenolate mofetil (128794-94-5) Usage
Mycophenolate mofetil was launched in 1995 in the U.S.A., its first market worldwide, for the prevention of acute kidney transplant rejection in conjunction with other immunosuppressive therapy and to treat refractory acute kidney graft rejection. With improved oral absorption and bioavailability, mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), a fermentation product of several Penicillium species. MPA is a selective, reversible, non-competitive inhibitor of inosinate dehydrogenase and guanylate synthetase. It inhibits the de now pathway of purine biosynthesis. MPA was found to have more potent antiproliferative effects on T and B lymphocytes than other cell types. Compared with other immunosuppressants, mycophenolate mofetil is reportedly superior due to its unique mechanism of action and excellent safety profile for long term use. Mycophenolate mofetil is being investigated clinically in the treatment of heart and liver transplantation rejection, asthma, in preventing coronary artery restenosis, and in treating rheumatoid arthritis.
How to get the best price on Mycophenolate mofetil?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Mycophenolate mofetil . You can buy high quality, low price Mycophenolate mofetil 128794-94-5 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
![3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/upload/2024/6/7731208f-d2ce-48e7-b978-042d4ccc1a08.gif)
